Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care).
Ombretta AnnibaliAlessia CastellinoNatalia CenfraMariavita CiccaroneFrancesco RotondoCarla MinoiaLuigi PetrucciGuido GiniChiara RusconiValentina BozzoliMaura NicolosiGloria MargiottaErika MeliFederica CocitoSara BigliardiSabino CiavarellaCristiano TeseiFrancesco ZajaPublished in: Leukemia & lymphoma (2024)
This is a retrospective, multicentric study, aimed to describe the real-life application of fertility preservation methods during treatment in female lymphoma patients, aged 18-40 years old, diagnosed between Oct 1st/2010 and May 31st/2018. Among 414 women included, median age was 28 years old, histologies were: HL 74%, PMBCL 13%, DLBCL 10%, others 3%. First line treatments were: ABVD in 295 (71%), R-CHOP like in 102 (25%), higher intensity regimens in 17 (4%) cases. Fertility preservation strategies were: GnRHa in 315 (78%), Oral Contraceptive in 41 (10%), oocytes and ovarian tissue cryopreservation in 55 and 42 patients, respectively. After therapy, we observed a restored regular period in 293 (70%) and premature ovarian failure (POF) in 33 (8%), Furthermore we recorded 43 pregnancies, all spontaneous with 5 years median follow-up. Median age at diagnosis and number of lines of treatment correlate with higher rate of amenorrhea, risk of POF and menopause ( p < 0.001).
Keyphrases
- diffuse large b cell lymphoma
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- prognostic factors
- healthcare
- peritoneal dialysis
- radiation therapy
- clinical trial
- palliative care
- stem cells
- squamous cell carcinoma
- pregnant women
- adipose tissue
- mesenchymal stem cells
- preterm birth
- skeletal muscle
- quality improvement
- radiation induced
- diabetic retinopathy
- locally advanced
- combination therapy